Impact of the new clinical breaking points proposed by the clinical and laboratory standards institute (CLSI) in the antifungal susceptibility profile of clinical strains isolated from invasive bloodstream Candida spp. infections in Spain

  1. Cisterna, R.
  2. Tellería, O.
  3. Hernaez, S.
  4. Ezpeleta, G.
Journal:
Clinical Medicine Insights: Therapeutics

ISSN: 1179-559X 1179-559X

Year of publication: 2012

Volume: 4

Pages: 19-27

Type: Article

DOI: 10.4137/CMT.S8293 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

info

SDG classification obtained using Aurora SDG artificial intelligence model.